How should I evaluate and manage a 45-year-old man presenting with insomnia, anxiety, and asthenia?

Evaluation and Management of a 45-Year-Old Man with Insomnia, Anxiety, and Asthenia

Start with cognitive-behavioral therapy for insomnia (CBT-I) as first-line treatment, while simultaneously addressing the anxiety disorder as a distinct condition—not as a secondary symptom—since treating anxiety alone will not resolve the insomnia. 1, 2

Initial Evaluation

Sleep History Assessment

Collect the following specific information during clinical interview:

• Sleep pattern details: Sleep onset latency, wake after sleep onset, total sleep time, number of awakenings, and sleep efficiency 1
• Sleep environment factors: Bedroom conditions, noise, light exposure, temperature 1
• Work and circadian factors: Work schedules, shift work history, bedtime/wake time consistency 1
• Sleep hygiene behaviors: Caffeine/alcohol use, exercise timing, screen time before bed 1
• Daytime consequences: Fatigue (asthenia), mood disturbances, cognitive dysfunction, quality of life impairment 1

Comorbidity Screening

• Anxiety disorder assessment: Use validated screening tools; younger adults (<45 years) are more likely to have anxiety linked to insomnia 3, 2
• Depression screening: Essential since insomnia commonly co-occurs with mood disorders 1, 2
• Medical conditions: Chronic pain, cardiovascular disease, endocrine disorders, neurological conditions 1
• Other sleep disorders: Screen for sleep apnea, restless legs syndrome, periodic limb movement disorder 1

Diagnostic Tools

• Sleep diary: Mandatory for 1-2 weeks before and during treatment to track sleep onset latency, wake time, total sleep time 1
• Questionnaires: Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI) 4
• Polysomnography: Only if you suspect sleep-disordered breathing, periodic limb movements, or treatment-resistant insomnia after initial therapy fails 1, 5
• Actigraphy: Not recommended for routine insomnia evaluation but may help with differential diagnosis 5

Treatment Algorithm

Step 1: First-Line Treatment - CBT-I (Weeks 0-8)

Initiate CBT-I immediately as the primary intervention for both insomnia and as an adjunct to anxiety treatment. 1, 6

Core CBT-I Components (must include at minimum):

• Stimulus control therapy: Go to bed only when sleepy; use bed only for sleep and sex; leave bedroom if unable to sleep within 15-20 minutes; maintain consistent wake time 1
• Sleep restriction therapy: Limit time in bed to match actual sleep time (calculate from sleep diary), then gradually increase as sleep efficiency improves to >85% 1
• Cognitive therapy: Address dysfunctional beliefs about sleep, catastrophic thinking about insomnia consequences 1
• Relaxation training: Progressive muscle relaxation, diaphragmatic breathing, or guided imagery 1

Sleep Hygiene (adjunctive only):

• Regular exercise (not within 3 hours of bedtime)
• Avoid caffeine after 2 PM, limit alcohol
• Cool, dark, quiet bedroom environment
• Critical caveat: Sleep hygiene alone is ineffective and must be combined with behavioral interventions 1

Delivery Format:

• 5-6 sessions over 6-8 weeks (individual or group format acceptable) 6
• Can be delivered by trained "sleep coaches" under supervision 6
• Digital CBT-I platforms are effective alternatives if in-person therapy unavailable 5, 7

Monitoring Schedule:

• Reassess every 2-4 weeks during initial treatment phase 1
• Continue sleep diary throughout treatment 1
• Follow-up every 6 months long-term due to high relapse rates 1

Step 2: Anxiety Treatment (Concurrent with CBT-I)

Treat anxiety as a separate disorder requiring its own intervention—do not assume treating anxiety will resolve insomnia. 2

• Consider anxiety management training (AMT) or progressive relaxation specifically for anxiety symptoms 8
• If moderate-to-severe anxiety disorder, consider SSRI/SNRI therapy (separate from insomnia pharmacotherapy) 1
• Coordinate timing: sedating antidepressants can serve dual purpose if both conditions require medication (see Step 3) 1

Step 3: Pharmacotherapy (If CBT-I Insufficient After 6-8 Weeks)

Add short-term pharmacotherapy only after adequate CBT-I trial, using shared decision-making to discuss benefits, harms, and costs. 4, 1

Medication Selection Criteria (in order of priority):

1. Symptom pattern: Sleep-onset vs. sleep-maintenance difficulty 1
2. Comorbid anxiety: Influences choice toward sedating antidepressants 1
3. Age considerations: Avoid benzodiazepines in older adults when possible 9
4. Past treatment responses 1
5. Drug interactions and contraindications 1
6. Cost and availability 1

First-Line Pharmacologic Options:

For sleep-onset insomnia:

• Zaleplon 5-10 mg at bedtime (ultra-short half-life, minimal morning sedation) 1
• Ramelteon 8 mg at bedtime (melatonin receptor agonist, no dependence risk) 1
• Zolpidem 5-10 mg at bedtime (short-acting) 1

For sleep-maintenance insomnia:

• Eszopiclone 1-3 mg at bedtime (longer half-life) 1
• Temazepam 7.5-15 mg at bedtime (intermediate-acting benzodiazepine) 1

For comorbid anxiety/depression (dual benefit):

• Trazodone 25-100 mg at bedtime (sedating antidepressant, first choice for anxiety comorbidity) 1
• Mirtazapine 7.5-15 mg at bedtime (sedating, also treats anxiety/depression) 1
• Doxepin 3-6 mg at bedtime (low-dose for insomnia, higher doses for depression) 1, 9

Second-Line Options (if first agent fails):

• Try alternative short-intermediate acting benzodiazepine receptor agonist or ramelteon 1
• Consider dual orexin receptor antagonists (suvorexant, daridorexant) for up to 3 months 5, 9

Third-Line Options (refractory cases):

• Gabapentin 300-900 mg at bedtime (if chronic pain also present) 1
• Combined therapy: BzRA + sedating antidepressant 1

Medications to AVOID:

• Over-the-counter antihistamines (diphenhydramine, doxylamine): Lack efficacy/safety data, anticholinergic effects problematic in middle-aged adults 1
• Herbal supplements (valerian, melatonin supplements): Insufficient evidence 1
• Barbiturates and chloral hydrate: Unsafe for chronic use 1
• Antipsychotics (quetiapine, olanzapine): Reserve only for patients with primary psychiatric indication requiring these agents 1, 5

Prescribing Principles:

• Start low, go slow: Use lowest effective dose 1
• Short-term use: Limit initial prescription to ≤4 weeks 1, 5
• Dosing schedule: Can be nightly, intermittent (3 nights/week), or as-needed based on symptom pattern 1
• Taper when stable: Reduce dose gradually when insomnia improves; tapering is easier when CBT-I continues 1
• Long-term use: May be necessary for severe/refractory cases, but requires ongoing CBT-I trial and regular monitoring 1
• Follow-up: Every 2-4 weeks initially to assess efficacy, side effects, tolerance, and need for continuation 1

Patient Education (mandatory with any prescription):

• Treatment goals and realistic expectations 1
• Potential side effects (morning sedation, cognitive impairment, falls risk) 1
• Drug interactions (especially with alcohol, other CNS depressants) 1
• Dependence/tolerance risk with benzodiazepines 1
• Rebound insomnia upon discontinuation 1
• Importance of continuing behavioral strategies 1

Step 4: Combined Therapy Considerations

Combined CBT-I plus medication shows no consistent advantage over CBT-I alone, but may be appropriate based on severity and patient preference. 1

Indications for combined approach:

• Severe insomnia with marked daytime impairment requiring rapid symptom relief 1
• Patient preference after discussing risks/benefits 1
• Comorbid conditions (anxiety, depression, chronic pain) requiring pharmacotherapy 1
• Failed monotherapy with either CBT-I or medication alone 1

Implementation:

• Start both interventions simultaneously if severe symptoms 1
• Plan medication taper once CBT-I skills established (typically 8-12 weeks) 1
• Continue CBT-I maintenance strategies indefinitely 1

Management of Asthenia (Fatigue)

Asthenia will likely improve as insomnia and anxiety are treated, but requires specific assessment:

• Distinguish between sleepiness (sleep debt) vs. fatigue (lack of energy despite adequate sleep) 1
• Rule out medical causes: Anemia, thyroid dysfunction, vitamin deficiencies, chronic infections 1
• Monitor as treatment outcome: Fatigue should decrease with improved sleep quality and anxiety reduction 1, 6
• If persistent after 3 months of insomnia/anxiety treatment, investigate other causes 1

Common Pitfalls to Avoid

1. Do not treat anxiety alone expecting insomnia to resolve: Insomnia requires direct treatment even when comorbid with psychiatric conditions 2
2. Do not prescribe hypnotics without behavioral therapy: Medication alone has limited long-term effectiveness 1, 3
3. Do not rely on sleep hygiene education alone: It must be combined with stimulus control, sleep restriction, or cognitive therapy 1
4. Do not continue ineffective medication: If no improvement after 2-4 weeks, switch agents or add CBT-I 1
5. Do not use polysomnography for routine insomnia diagnosis: Reserve for suspected sleep-disordered breathing or treatment-resistant cases 1, 5
6. Do not ignore the high relapse rate: Schedule 6-month follow-ups indefinitely 1

Reassessment Triggers

Reevaluate for occult comorbid disorders if:

• No improvement after 8 weeks of adequate CBT-I 1
• Worsening symptoms despite treatment adherence 1
• New onset of snoring, witnessed apneas, or excessive daytime sleepiness (consider sleep apnea) 1
• Restless legs symptoms or limb movements during sleep 1